GAD2
Basic information
Region (hg38): 10:26216665-26304558
Links
Phenotypes
GenCC
Source: 
ClinVar
This is a list of variants' phenotypes submitted to 
- not_specified (69 variants)
 - not_provided (10 variants)
 
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GAD2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001134366.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum | 
|---|---|---|---|---|---|---|
| synonymous | 4 | |||||
| missense | 69 | 73 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 69 | 3 | 5 | 
GnomAD
Source: 
| Gene | Type | Bio Type | Transcript | Coding Exons | Length | 
|---|---|---|---|---|---|
| GAD2 | protein_coding | protein_coding | ENST00000376261 | 16 | 88252 | 
| pLI Probability LOF Intolerant  | pRec Probability LOF Recessive  | Individuals with no LOFs  | Individuals with Homozygous LOFs  | Individuals with Heterozygous LOFs  | Defined | p | 
|---|---|---|---|---|---|---|
| 0.751 | 0.249 | 125738 | 0 | 10 | 125748 | 0.0000398 | 
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.53 | 258 | 337 | 0.766 | 0.0000175 | 3863 | 
| Missense in Polyphen | 100 | 174.89 | 0.5718 | 2023 | ||
| Synonymous | 0.0258 | 123 | 123 | 0.997 | 0.00000688 | 1062 | 
| Loss of Function | 4.42 | 7 | 35.4 | 0.198 | 0.00000167 | 409 | 
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p | 
|---|---|---|
| African & African-American | 0.0000906 | 0.0000906 | 
| Ashkenazi Jewish | 0.0000992 | 0.0000992 | 
| East Asian | 0.0000544 | 0.0000544 | 
| Finnish | 0.00 | 0.00 | 
| European (Non-Finnish) | 0.0000442 | 0.0000439 | 
| Middle Eastern | 0.0000544 | 0.0000544 | 
| South Asian | 0.0000329 | 0.0000327 | 
| Other | 0.00 | 0.00 | 
dbNSFP
Source: 
- Function
 - FUNCTION: Catalyzes the production of GABA.;
 - Pathway
 - Alanine, aspartate and glutamate metabolism - Homo sapiens (human);Type I diabetes mellitus - Homo sapiens (human);GABAergic synapse - Homo sapiens (human);Butanoate metabolism - Homo sapiens (human);beta-Alanine metabolism - Homo sapiens (human);Taurine and hypotaurine metabolism - Homo sapiens (human);Alanine and aspartate metabolism;One carbon metabolism and related pathways;Biogenic Amine Synthesis;Alanine Aspartate Asparagine metabolism;Glutamate Glutamine metabolism;Methionine Cysteine metabolism;Neuronal System;glutamate dependent acid resistance;Methionine and cysteine metabolism;Urea cycle and metabolism of arginine, proline, glutamate, aspartate and asparagine;Arginine Proline metabolism;GABA shunt;GABA synthesis;GABA synthesis, release, reuptake and degradation;Neurotransmitter release cycle;Transmission across Chemical Synapses 
(Consensus)  
Recessive Scores
- pRec
 - 0.862
 
Intolerance Scores
- loftool
 - 0.533
 - rvis_EVS
 - -0.11
 - rvis_percentile_EVS
 - 45.36
 
Haploinsufficiency Scores
- pHI
 - 0.461
 - hipred
 - Y
 - hipred_score
 - 0.850
 - ghis
 - 0.582
 
Essentials
- essential_gene_CRISPR
 - N
 - essential_gene_CRISPR2
 - N
 - essential_gene_gene_trap
 - N
 - gene_indispensability_pred
 - E
 - gene_indispensability_score
 - 0.995
 
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium | 
| Primary Immunodeficiency | Medium | Medium | Medium | 
| Cancer | Medium | Medium | Medium | 
Mouse Genome Informatics
- Gene name
 - Gad2
 - Phenotype
 - craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; immune system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
 
Gene ontology
- Biological process
 - glutamate decarboxylation to succinate;chemical synaptic transmission;neurotransmitter biosynthetic process;response to drug
 - Cellular component
 - Golgi membrane;cytosol;plasma membrane;cell junction;axon;synaptic vesicle membrane;anchored component of membrane;presynaptic membrane;perinuclear region of cytoplasm;inhibitory synapse;clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane
 - Molecular function
 - glutamate decarboxylase activity;protein binding;glutamate binding;pyridoxal phosphate binding;protein heterodimerization activity